Federal Circuit Vacates & Remands in Maquet v. Abiomed Blood Pump Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Maquet Cardiovascular, LLC v. Abiomed, Inc. |
| Case Number | 23-2045 (Fed. Cir.) |
| Court | Federal Circuit (D.C. Region), Appeal from lower court |
| Duration | June 2023 – March 2025 640 Days |
| Outcome | Vacated & Remanded |
| Patents at Issue | |
| Accused Products | Intravascular Blood Pump Systems (Impella device family) |
Case Overview
The Parties
⚖️ Plaintiff
A subsidiary of Getinge Group and a developer of advanced cardiovascular surgical and critical care technologies, holding a substantial cardiac support IP portfolio.
🛡️ Defendant
Now a Johnson & Johnson MedTech company, maker of the market-leading Impella line of percutaneous heart pumps, with co-defendants Abiomed Europe, GmbH and Abiomed R&D, Inc.
Patents at Issue
This dispute centers on two patents covering intravascular blood pump technology, critical for cardiac support:
- • US10238783B2 — A continuation patent covering intravascular blood pump system design and operation.
- • US9789238B2 — An earlier-generation patent in the same family, addressing structural and functional aspects of intravascular pump systems.
Designing a similar medical device?
Check if your cardiovascular device might infringe these or related patents.
The Verdict & Legal Analysis
Outcome
The Federal Circuit issued a disposition stating: *”THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: VACATED AND REMANDED.”* The court **vacated** the lower tribunal’s ruling and **remanded** the case for further proceedings, without determining damages or injunctive relief.
Key Legal Issues
A Federal Circuit vacatur in this posture most commonly arises from errors in **claim construction**, insufficient **factual findings**, or misapplication of **legal standards** governing patent validity or infringement doctrine, requiring lower court reconsideration.
Filing a utility patent?
Learn from this case. Use AI to draft stronger claims for medical devices.
Power Your Patent Strategy with Eureka IP
From novelty searches to patent drafting, Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in medical device patent litigation. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation on intravascular blood pumps.
- View all patents in this technology space
- See companies active in mechanical circulatory support IP
- Understand Federal Circuit claim construction trends
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Intravascular Blood Pump Systems
2 Patents at Issue
Key to mechanical circulatory support
Claim Construction Critical
Outcome depends on claim interpretation
✅ Key Takeaways
For Patent Attorneys & Litigators
Federal Circuit vacatur in patent infringement cases most frequently turns on *de novo* claim construction review – invest in airtight claim term definitions.
Search related case law →Continuation patent families (like US10238783B2/US9789238B2) create layered infringement risk; map each claim scope carefully.
Explore precedents →For R&D Leaders
Conduct thorough FTO clearances for medical devices, especially against continuation patent families that extend IP exposure.
Start FTO analysis for my product →Build patent risk checkpoints into device development timelines to proactively address evolving IP exposure.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.